Atrial Flow Regulator
AFR implantation is a valuable bridging strategy to LTX in pediatric patients with therapy-refractory PAH, enabling clinical stabilization and safer perioperative management. Post-transplant transcatheter closure is reasonable to reduce long-term risks associated with persistent atrial shunting.
Authors
- Julia Moosmann (ORCID: https://orcid.org/0000-0002-8843-7084)
- Anastasia Schleiger (ORCID: https://orcid.org/0000-0002-2008-2483)
- Peter Krämer (ORCID: https://orcid.org/0000-0003-4780-5271)
- Felix Berger (ORCID: https://orcid.org/0000-0002-2826-1363)
Institutions
- Humboldt-Universität zu Berlin (DE)
- Deutsches Herzzentrum der Charité (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106118
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00